Looking for Something?

Atrium Health’s Levine Cancer Institute was officially established in 2012, launching the evolution of a multi-site, distributed cancer treatment and research facility.

As one of the leading and most innovative cancer care facilities in the country, the Institute operates within a unique model of care that provides diverse communities access to world class care, close to home. This academic hybrid model combines two important bodies of work – academics and oncology research – with compassionate, community-based cancer care. Levine Cancer Institute has been recognized by US News and World Report as one of the top 50 cancer centers in the country. Learn more here.

In 2019, Atrium Health’s Levine Cancer Institute opened an addition to the world- renowned cancer institute: Levine Cancer Institute II (LCI II). LCI II includes nearly 31,000 square feet dedicated to research which will allows for centralized oncology and hematology research as Levine Cancer Institute continued to invest in the development of clinical trials and other research to make it easier and more convenient for patients to access to groundbreaking therapies. Multi-site Phase 1 clinical trials unit provides access to the newest, most innovative therapies and cancer treatment options available.

The Atrium Health Levine Cancer Proton and Advanced Radiation Center will be open to patients in 2024, first offering gamma knife radiosurgery treatments, followed in mid-to-late 2024 by proton beam therapy sessions. When all services are available to patients, the Atrium Health Levine Cancer Proton and Advanced Radiation Center will be the only location offering proton therapy treatments between Washington, D.C., and Atlanta, and one of just 44 proton beam therapy sites in the country.

Levine Cancer Institute cares for over 20,000 patients annually. With more than 25 cancer care locations, they provide access to top-ranked physician expertise, groundbreaking clinical trials and the latest cancer treatments across the Carolinas.

Levine Cancer’s sarcoma team consists of fellowship-trained physicians in orthopedic oncology, surgical oncology, medical oncology and sarcoma pathology.

In 2024 the Paula Takacs Foundation announced the Paula Takacs Foundation Endowed Chair of Sarcoma Research at Levine Cancer Institute with the establishment of a $2 million endowment fund.

Meet the Physician Researchers of Levine Cancer Institute

Physician researchers at Levine Cancer Institute passionately detail how the research partnership with our foundation elevates hope, increases awareness, and creates community.


Strong Partnership: The Paula Takacs Foundation & Levine Cancer Institute

Dr. Derek Raghavan, former President of Atrium Health’s Levine Cancer Institute, speaks about the impact the Paula Takacs Foundation for Sarcoma Research’s funding has on their cancer center’s sarcoma research.


Levine Children’s Hospital treats more pediatric patients per day than any other hospital in North Carolina.

Its board-certified physicians in more than 30 areas of pediatric medicine deliver exceptional specialty care that relies on clinical excellence, innovative research and the latest technologies to improve the health of patients. U.S. News & World Report ranks this hospital among the nation’s best hospitals for pediatric cancer care.

Dr. Thomas Russell is the director of the Isabella Santos Foundation Solid and Rare Tumor Program at Levine Children’s. He is board certified in pediatrics and pediatric hematology-oncology (cancer and blood disorders).

Dr. Russell has clinical interests in solid tumor research focusing on translational research and clinical trials development for pediatric sarcoma patients.

Dr. Russell spent the last decade of his career as a Hematologist/Oncologist at Brenner Children’s Hospital at Atrium Health Wake Forest Baptist developing his clinical expertise in pediatric solid tumor cancers with a specific interest in sarcoma.  As an Associate Professor, Dr. Russell held various roles within the Wake Forest University School of Medicine including serving as program director for the Pediatric Residency.  He has demonstrated a passion for scholarly endeavors with a wide range of pursuits and has served as the primary investigator for the Children’s Oncology Group.

"The work of the Paula Takacs Foundation is vital to the Levine Cancer Institute's sarcoma research program, enabling us to conduct innovative, scientifically based clinical trials and molecular studies in order to improve the outcomes of treatment. In parallel, we are also able to refine our understanding of the biology and natural history of this set of rare and potentially deadly cancers."


Former President, Atrium Health’s Levine Cancer Institute

Attending Medical Oncologist at Veterans Administration Health Care Center

Our Top Supporters